Data / Drug companies / Guaifenesin, dextromethorphan hbr
Guaifenesin, dextromethorphan hbr: 26 companies and 36 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Guaifenesin, dextromethorphan hbr is listed in the FDA National Drug Code Directory by 26 companies, with 36 products in commercial distribution. 29 of the products (80.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, extended release; liquid, and the newest product started marketing on June 16, 2026.
The request: Get every company that lists guaifenesin, dextromethorphan hbr in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 26
- Products
- 36
- Generic (ANDA) products
- 29 (80.6%)
- Application numbers
- 5
- Routes
- Oral
- Brand names
- Mucus Relief DM, Mucus Relief DM Extended Release Caplets, Mucus Relief DM, Mucus Relief DM Maximum Strength, NeoTuss S/F Grape-Menthol Flavor, Mucus Relief - DM Maximum Strength, Mucus Relief DM Extended Release Caplets Maximum Strength, Defensol Adult Syrup
- openFDA record search
- api.fda.gov
Companies that list guaifenesin, dextromethorphan hbr
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| H E B | 3 | tablet, extended release | Generic drugs (ANDA) | March 15, 2023 |
| Doral Pharmamedics Inc DBA A.G. Marin Pharmaceuticals | 2 | liquid | Over the counter monograph drugs | March 6, 2025 |
| Family Dollar (family Wellness) | 2 | tablet, extended release | Generic drugs (ANDA) | April 1, 2025 |
| Retail Business Services, LLC | 2 | tablet | Generic drugs (ANDA) | July 23, 2021 |
| Rite Aid Corporation | 2 | tablet | Generic drugs (ANDA) | May 31, 2019 |
| Strategic Sourcing Services LLC | 2 | tablet, extended release | Generic drugs (ANDA) | March 31, 2023 |
| Valu Merchandisers Company | 2 | tablet | Generic drugs (ANDA) | January 14, 2022 |
| Walgreen Company | 2 | tablet | Generic drugs (ANDA) | January 1, 2019 |
| Yyba Corp | 2 | tablet, extended release; tablet | Generic drugs (ANDA) | June 16, 2026 |
| A-S Medication Solutions | 1 | tablet | Generic drugs (ANDA) | November 5, 2018 |
| Advanced Rx LLC | 1 | tablet | Over the counter monograph drugs | January 1, 2025 |
| Atlantic Biologicals Corp. | 1 | tablet, extended release | Generic drugs (ANDA) | December 13, 2018 |
| Bi-Mart | 1 | tablet | Over the counter monograph drugs | June 1, 2025 |
| CVS Pharmacy | 1 | tablet, extended release | Generic drugs (ANDA) | May 3, 2018 |
| Cardinal Health 110, LLC. DBA Leader | 1 | tablet | Generic drugs (ANDA) | December 31, 2018 |
| Chain Drug Consortium, LLC | 1 | tablet | Generic drugs (ANDA) | November 29, 2019 |
| Chain Drug Marketing Association | 1 | tablet | Generic drugs (ANDA) | December 31, 2018 |
| Dolgencorp, Inc. (dollar General & Rexall) | 1 | tablet | Generic drugs (ANDA) | March 31, 2019 |
| Fsa Store Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | December 31, 2023 |
| Menper Distributors, Inc. | 1 | liquid | Over the counter monograph drugs | February 21, 2012 |
| Opmx LLC | 1 | capsule, liquid filled | Over the counter monograph drugs | February 18, 2019 |
| P & L Development, LLC | 1 | tablet | Generic drugs (ANDA) | December 31, 2018 |
| Rising Pharma Holdings, Inc. | 1 | liquid | Over the counter monograph drugs | December 22, 2025 |
| Rugby Laboratories | 1 | tablet, extended release | Generic drugs (ANDA) | December 13, 2018 |
| Wal-Mart Stores Inc | 1 | tablet | Generic drugs (ANDA) | November 29, 2019 |
| WinCo Foods, LLC | 1 | tablet | Generic drugs (ANDA) | September 1, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 19 | 52.8% |
| Tablet, extended release | 12 | 33.3% |
| Liquid | 4 | 11.1% |
| Capsule, liquid filled | 1 | 2.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 29 | 80.6% |
| Over the counter monograph drugs | 7 | 19.4% |
Pharmacologic classes
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.